ID

34166

Description

Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02065960

Link

https://clinicaltrials.gov/show/NCT02065960

Keywords

  1. 1/14/19 1/14/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 14, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Neoplasm NCT02065960

Eligibility Breast Neoplasm NCT02065960

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
women age ≥ 70 years;
Description

ID.1

Data type

boolean

new histological diagnosis of invasive carcinoma of the breast, grade i or ii, estrogen and progesterone receptor (er and pr) positive, her2 negative on needle biopsy and limited to stage i (t1 n0 m0) on clinical and radiological assessment with mri of the breasts and axillary ultrasound;
Description

ID.2

Data type

boolean

candidate for breast conserving surgery;
Description

ID.3

Data type

boolean

signed study consent form completed prior to study entry.
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
breast cancer with disease within 5 mm from skin or chest wall;
Description

ID.5

Data type

boolean

previous or concomitant invasive malignancies treated within 5 years of study entry;
Description

ID.6

Data type

boolean

serious non-malignant disease (cardiovascular, pulmonary, systemic lupus or scleroderma), which would preclude to definitive radiation therapy;
Description

ID.7

Data type

boolean

psychiatric disorders, which would preclude from obtaining informed consent
Description

ID.8

Data type

boolean

geographic inaccessibility for follow-up
Description

ID.9

Data type

boolean

Similar models

Eligibility Breast Neoplasm NCT02065960

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
women age ≥ 70 years;
boolean
ID.2
Item
new histological diagnosis of invasive carcinoma of the breast, grade i or ii, estrogen and progesterone receptor (er and pr) positive, her2 negative on needle biopsy and limited to stage i (t1 n0 m0) on clinical and radiological assessment with mri of the breasts and axillary ultrasound;
boolean
ID.3
Item
candidate for breast conserving surgery;
boolean
ID.4
Item
signed study consent form completed prior to study entry.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
breast cancer with disease within 5 mm from skin or chest wall;
boolean
ID.6
Item
previous or concomitant invasive malignancies treated within 5 years of study entry;
boolean
ID.7
Item
serious non-malignant disease (cardiovascular, pulmonary, systemic lupus or scleroderma), which would preclude to definitive radiation therapy;
boolean
ID.8
Item
psychiatric disorders, which would preclude from obtaining informed consent
boolean
ID.9
Item
geographic inaccessibility for follow-up
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial